As Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...

India's drug regulator has approved Gennova's mRNA vaccine for restricted use in emergency situations in adults. Samit Mehta, chief operati...

India's drug regulator approved Gennova's mRNA vaccine for restricted use in emergency situations in adults early this week.

Since Gennova has the manufacturing-at-risk approval, it has already produced 7 million doses that have been released not only by the compa...

The Subject Expert Committee recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biop...

About 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...

Gennova had in April submitted interim data on India's first indigenously developed mRNA Covid-19 vaccine to the Central Drug Standard Cont...

Gennova had last month submitted interim data on India's first indigenously developed mRNA Covid vaccine to the drug regulator. The Central...

Pune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19. The subject expert committee under t...

Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...

The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.

To assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regul...

The DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...

The recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...

"Tomorrow, on 30th November, 2020, PM @narendramodi will interact, via video conferencing, with three teams that are involved in developing...

The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...

Pune-based biotechnology company Gennova Biopharmaceuticals will soon start human clinical trials of a Covid-19 vaccine candidate, joining ...